American Exceptionalism Acquisition Corp. A
NYSE:AEXAAsset Management
-$0.04 today
- Market cap
- $368.60M
- Beta
- 0.41
- P/E (TTM)
- 192.1
- EPS (TTM)
- $0.06
Volume 0.09M
Average 0.10M
AEXA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
American Exceptionalism Acquisition Corp. ANYSE: AEXA
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA of $0 in Q1 FY2026
Q1 FY2026 EBITDA was $0.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA history
Currency unavailable · from the income statement
No EBITDA data reported for this period type.
EBITDA vs competitors
How AEXA compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $422.62M USD | +2477.5% | — | 692.5% | |
| LTM Mar 2026 | $79.24M USD | +58.4% | — | 96.3% | |
| LTM Mar 2026 | $50.46M USD | -43.5% | +48.9% | 71.5% | |
| LTM Feb 2026 | $38.09M USD | +19.1% | +12.5% | 38.4% | |
| LTM Jun 2025 | $19.88M USD | -44.6% | +22.3% | 48.4% | |
| LTM Dec 2025 | -$85.17M USD | -57989.8% | — | 50.8% | |
BRRProCap Financial, Inc. | LTM Mar 2026 | -$136.1M USD | — | — | 158261.0% |
AEXAAmerican Exceptionalism Acquisition Corp. A | — | — | — | — | — |
TLNCTalon Capital Corp. Class A Ordinary Shares | — | — | — | — | — |
BCARD. Boral ARC Acquisition I Corp. Class A Ordinary Shares | — | — | — | — | — |
| Peer median (excluding AEXA) | — | -12.2% | +22.3% | 71.5% | |
Competitors are the stored peer set for AEXA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
American Exceptionalism Acquisition Corp. A
NYSE:AEXA
Intrinsic Alpha fair value
Locked
Current Price
$10.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.